6P9U

Crystal structure of human thrombin mutant W215A

6P9U の概要

• エントリーDOI: 10.2210/pdb6p9u/pdb
• 関連するPDBエントリー: 1SHH
• 分子名称: Prothrombin, ZINC ION, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
• 機能のキーワード: trypsin-like protease, allosteric equilibrium, closed and open conformations, hydrolase
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 141170.61

構造登録者

Pelc, L.A.,Koester, S.K.,Chen, Z.,Di Cera, E. (登録日: 2019-06-10, 公開日: 2019-09-04, 最終更新日: 2024-10-09)

主引用文献

Pelc, L.A.,Koester, S.K.,Chen, Z.,Gistover, N.E.,Di Cera, E.
Residues W215, E217 and E192 control the allosteric E*-E equilibrium of thrombin.
Sci Rep, 9:12304-12304, 2019

PubMed Abstract: A pre-existing, allosteric equilibrium between closed (E*) and open (E) conformations of the active site influences the level of activity in the trypsin fold and defines ligand binding according to the mechanism of conformational selection. Using the clotting protease thrombin as a model system, we investigate the molecular determinants of the E*-E equilibrium through rapid kinetics and X-ray structural biology. The equilibrium is controlled by three residues positioned around the active site. W215 on the 215-217 segment defining the west wall of the active site controls the rate of transition from E to E* through hydrophobic interaction with F227. E192 on the opposite 190-193 segment defining the east wall of the active site controls the rate of transition from E* to E through electrostatic repulsion of E217. The side chain of E217 acts as a lever that moves the entire 215-217 segment in the E*-E equilibrium. Removal of this side chain converts binding to the active site to a simple lock-and-key mechanism and freezes the conformation in a state intermediate between E* and E. These findings reveal a simple framework to understand the molecular basis of a key allosteric property of the trypsin fold.

PubMed: 31444378
DOI: 10.1038/s41598-019-48839-1

実験手法

X-RAY DIFFRACTION (3.3 Å)